Pages with the fewest revisions

From IDWiki

Showing below up to 50 results in range #101 to #150.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. CR:DOI:e7d5997f6ba302aad44373195ab7f4fa (1 revision)
  2. CR:DOI:88f1c13f8624165c561faaf6182ce60b (1 revision)
  3. PAM (1 revision)
  4. Moringa (1 revision)
  5. Model for end-stage liver disease (1 revision)
  6. CR:DOI:3c928b7df7a9405c7077dbadb984160c (1 revision)
  7. Myelodysplastic disorders (1 revision)
  8. CR:DOI:4f321b17bc465b962821ea408b2d7e8a (1 revision)
  9. CR:DOI:04a5dc868a20c01a03876869d21968ee (1 revision)
  10. Ibrexafungerp (1 revision)
  11. Intubation (1 revision)
  12. CR:DOI:cfa2f2c6cc6af3632365c3ef86e7b61b (1 revision)
  13. CR:DOI:c3e77e6274ea49f5549116beb46606b7 (1 revision)
  14. CR:DOI:6488adb7ce6690a2b5ec71fdb784203d (1 revision)
  15. Autoimmune hepatitis (1 revision)
  16. Viral gastroenteritis (1 revision)
  17. Acute mountain sickness (1 revision)
  18. CCU drugs and concentrations (1 revision)
  19. Irregular periods (1 revision)
  20. Mycobacterium szulgai (1 revision)
  21. Postural vital signs (1 revision)
  22. Toll-like receptors (1 revision)
  23. CR:DOI:3917348f8490a2874a73be4769774c60 (1 revision)
  24. CR:DOI:73b23397ddf1b35e6e13135126af8592 (1 revision)
  25. Left shift (1 revision)
  26. Diabetic foot ulcer (1 revision)
  27. CR:DOI:c5086c57c4ad4641b7ee0e15b2ed35a2 (1 revision)
  28. Hand-Schüller-Christian disease (1 revision)
  29. Plazomicin (1 revision)
  30. CR:DOI:6920036664d2ce14878b939de0c03bee (1 revision)
  31. CR:DOI:683a799d2c3a950ee88512dee71f0649 (1 revision)
  32. Left renal vein entrapment (1 revision)
  33. MRC Strength Grades (1 revision)
  34. Yeasts (1 revision)
  35. Geriatric Depression Scale (1 revision)
  36. Autosomal dominant polycystic kidney disease (1 revision)
  37. CR:DOI:b7d2eb575c72075fbc611e031639265c (1 revision)
  38. CR:DOI:5f48b1fa391b1e412ae002eff571f917 (1 revision)
  39. CR:DOI:2f556ae27a0ead10bdc78afc7d591782 (1 revision)
  40. Preterm premature rupture of membranes (1 revision)
  41. MS (1 revision)
  42. CR:DOI:2483a49cfbd2a70760de3abb1cb8a780 (1 revision)
  43. Primary biliary cholangitis (1 revision)
  44. CR:DOI:1e0f196e8979f77a82c63ac7c9a6256a (1 revision)
  45. Nitroglycerine (1 revision)
  46. Lupus nephritis (1 revision)
  47. CR:DOI:040ca4f27ba6b86983650733d3b2c378 (1 revision)
  48. CR:DOI:d7e82ec5e5ad23fe3de0c2225396c4f1 (1 revision)
  49. CR:DOI:20ae50585c42ac82c0fd193628155d30 (1 revision)
  50. Efalizumab (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)